ET-1, produced by tumour cells, exerts its effects primarily by binding to G-protein-coupled receptors on the cell surface (endothelin A receptor (ETA) and B receptor (ETB)) (Nelson et al, 2003) and modifying the effects of other growth factors (Nelson et al, 1995). This evidence concerns the gene EDN1 and neoplasm.